Today: 13 May 2026
Dow Dips as Fed Fears Slam Tech Stocks – Hot Economic Data Rattles Wall Street (Sept 25, 2025)

Regional Banks Roar Back? Q3 Surprises, Mega‑Mergers—and the One Risk Still Haunting 2025

Key facts (updated Nov. 5, 2025):

  • Sector snapshot. The SPDR S&P Regional Banking ETF (KRE) traded at $59.82 (-0.5% intraday). Notable movers: Zions (ZION) $51.45, Western Alliance (WAL) $77.45, FB Financial (FBK) $53.75, Fifth Third (FITB) $42.15, Comerica (CMA) $77.38 (all times ~01:15–10:25 UTC).
  • Earnings wrap. A broad Q3 review found 94 regional banks’ revenues missed consensus by ~1.2% on average—but the group’s shares outperformed heading out of earnings.
  • Rates & lending. After two Fed cuts this fall (most recently Oct. 29), the Fed’s October SLOOS said standards were basically unchanged for households, with stronger mortgage and HELOC demand.
  • Consolidation wave. Three headline deals define the new landscape: Fifth Third’s $10.9B all‑stock deal for Comerica (closing target: Q1 2026), PNC’s $4.1B purchase of FirstBank, and the $8.6B Pinnacle–Synovus merger.
  • Flows flash caution. KRE logged ~$619.3M of outflows last week, a 16.3% drop in units outstanding.
  • CRE stress is the swing factor.Trepp’s October data: overall CMBS delinquency 7.46%; office delinquency at a record ~11.76%.
  • Standout regional result.FB Financial (FBK) Q3: diluted EPS $0.43 (adj. $1.07); NIM 3.95%; loans and deposits jumped with its Southern States merger. CEO Christopher T. Holmes said the bank “establish[ed] a strong foundation for future growth.” investors.firstbankonline.com
  • What spooked markets in October.Zions disclosed $50M of losses tied to two loans; Western Alliance filed a fraud suit involving Cantor Group V, LLC; Cantor Fitzgerald said it has no affiliation with that entity.
  • Tech spend still healthy.Jack Henry (JKHY) reported a ~21% profit jump on resilient demand from community banks for core and payments tech.
  • Outlook watch. Nomura now expects no additional Fed cuts in 2025 after October’s move—lowering the odds of a rapid funding‑cost tailwind.

Q3 in one chartless glance: earnings stabilized, but credit is still a coin flip

After two straight Fed cuts took the policy range down again in late October, the October Senior Loan Officer Opinion Survey painted a nuanced picture: tighter C&I standards on balance, but basically unchanged CRE standards and stronger demand for mortgages and HELOCs. In other words, lending isn’t shutting down, but banks are still protective—especially on business credit.

On the scoreboard, a sweeping Yahoo Finance/StockStory Q3 roll‑up of 94 regional lenders found revenues missed by ~1.2% versus consensus—yet the group’s share prices held up as investors looked through near‑term net interest income pressure toward 2026 normalization.

What moved stocks this week

Prices (as of Nov. 5, UTC): KRE $59.82; ZION $51.45; WAL $77.45; FBK $53.75; FITB $42.15; CMA $77.38. The flow picture is less rosy: KRE saw ~$619M in outflows last week, suggesting money managers are still hedging credit‑quality uncertainty even as rates drift lower.

Winners and wobbles from Q3

  • Regions Financial (RF). Profit rose on capital‑markets rebound; the bank now expects NII up ~3–4% for the year—evidence that deposit costs may be close to peaking for some franchises.
  • Zions (ZION). A $50M charge‑off on two California C&I loans rattled the group in mid‑October. Zions said the rest of its book is behaving: “We are confident this was an isolated incident in our portfolio,” Chief Credit Officer Derek Steward told analysts. Reuters+1
  • Western Alliance (WAL). Announced litigation tied to Cantor Group V, LLC; Cantor Fitzgerald clarified that it has no affiliation with that entity.
  • FB Financial (FBK). The first full quarter including Southern States showed scale benefits: adj. EPS $1.07, NIM 3.95%, stronger PPNR, and management leaning into “a strong foundation for future growth.” Independent analysis also highlighted margin dynamics and a fair‑value gap vs. current price. investors.firstbankonline.com+1

Context from the user links: Yahoo Finance’s “Regional Banks Stocks Q3 In Review” frames the season, while Simply Wall St’s Q3 note on FBK (also reflected by local re‑publishers) underscores how a cleaner margin trajectory and integration progress can mark a new phase for select names. Yahoo Finance+2Simply Wall St+2

M&A is back—and it’s big

The deal math finally works again. Fifth Third agreed to acquire Comerica in a $10.9B all‑stock deal (1.8663 FITB shares per CMA share), aiming to close by Q1 2026. Breakingviews estimates the synergy value capture heavily favors FITB’s shareholders, reflecting sizeable cost saves. CFRA’s Alexander Yokum calls it a scale‑builder that “strengthen[s] [Fifth Third’s] commercial banking operations,” albeit with a slower pivot to the Southeast. Axios+3SEC+3Reuters+3

Two other transactions are reshaping the map: PNC’s $4.1B cash‑and‑stock purchase of FirstBank (Colorado/Arizona expansion) and an $8.6B all‑stock merger of Pinnacle and Synovus, both targeting closings in early 2026. Collectively, these moves reflect a regulatory climate friendlier to scale deals and a strategic push to diversify revenue beyond spread income.

The swing factor: Commercial real estate

The clearest near‑term risk sits in CRE, particularly office. Trepp reports that overall CMBS delinquency rose to 7.46% in October, with office at a record ~11.76%. A recent Fitch and Reuters drumbeat shows late payments and maturities still biting. Morningstar DBRS cautions that delinquencies and loan losses are likely to rise as inflation and geopolitics linger.

Banks are actively de‑risking. In June, Atlantic Union off‑loaded nearly $2B of CRE loans to Blackstone at a small discount—one of several transactions where regionals trade risk for liquidity. The move let AUB pay down pricier deposits and refocus its portfolio.

Macro helps at the margin: the Fed’s late‑October cut and SLOOS indicate easier demand for mortgages, but analysts warn the credit cycle’s timing—especially tied to 2025–2026 maturity walls—will drive reserve builds and loan growth pacing.

Expert voices

  • Zions’ CCO Derek Steward: “We are confident this was an isolated incident in our portfolio.” Reuters
  • CFRA’s Alexander Yokum (on FITB–CMA): “Significant scale benefits” strengthening FITB’s commercial bank—though CMA’s footprint slows the pivot southward. Axios
  • Morningstar DBRS (Michael Driscoll): Banks face more delinquencies and losses in coming quarters—sobering context for the rally.
  • Jack Henry read‑through: Banking‑tech spending remains resilient, supporting operational efficiency efforts at community/regional banks.

Stock prices & near‑term forecast

Today’s levels (UTC): KRE $59.82; ZION $51.45; WAL $77.45; FBK $53.75; FITB $42.15; CMA $77.38. Combined with last week’s KRE outflows, positioning is cautious even as macro tailwinds build from rate cuts.

Base case (next 6–12 months):

  • Net interest income stabilizes as deposit betas crest; rate cuts slowly help funding costs, but re‑pricing lags. Loan demand improves in mortgages/HELOCs; C&I appetite remains selective.
  • Credit costs stay lumpy. Office and certain CRE subsectors pressure provisions; multifamily and industrial look comparatively sturdier.
  • M&A remains a supportive rerating driver where synergies are clear and approvals timely (FITB–CMA, PNC–FirstBank, Pinnacle–Synovus).

Bull case: Faster disinflation + another modest Fed cut in early 2026 lower deposit costs faster than asset yields roll down; CRE workout activity accelerates and loss‑given‑default assumptions moderate. (Note: some forecasters don’t see more 2025 cuts.)

Bear case: Office distress spreads beyond CMBS into bank books, pulling up nonperformers and forcing heavier reserve builds; M&A integration risks dilute earnings; funding competition re‑intensifies if rates back up.

Company color—FB Financial (FBK): Management delivered a cleaner Q3 with adj. EPS $1.07 and NIM 3.95%; Street/independent models see earnings growth into 2026 as merger synergies season, though valuation debates persist (and some models highlight a fair‑value discount).

What to watch into year‑end

  1. FOMC minutes (Oct. 28–29 meeting) and rate‑path rhetoric—for clues on deposit‑cost relief cadence.
  2. CRE delinquency prints (Trepp/Fitch)—particularly office rollovers and extensions vs. refis.
  3. Deal approvals & synergy roadmaps for FITB–CMA, PNC–FirstBank, Pinnacle–Synovus.
  4. ETF flows (KRE) as a real‑time barometer of institutional risk appetite.

Sources & further reading

  • Q3 sector wrap: Yahoo Finance/StockStory regional‑bank earnings review.
  • User‑provided analysis links: Simply Wall St on FBK Q3 momentum; regional-bank take republished on EMEgypt.
  • FBK official Q3 release: EPS, NIM, loan/deposit growth; CEO commentary.
  • Market catalysts: Zions/WAL items and sector whipsaw (Reuters); Cantor Fitzgerald clarification.
  • Fed policy & lending: FOMC Oct. 29 statement; October 2025 SLOOS.
  • M&A wave: Fifth Third–Comerica (press releases/SEC; Reuters/AP/FT/Axios); PNC–FirstBank; Pinnacle–Synovus (company/Reuters).
  • Flows: KRE outflows (Nasdaq).
  • CRE stress: Trepp (CMBS/office); Fitch/Reuters context.
  • Tech spend read‑through: Jack Henry Q1 (Reuters).

This article is for information only and not investment advice. Markets move quickly; always check current prices and filings before making decisions.

Stock Market Today

  • Marvell Stock Rises As AMD Discloses $10M Stake Amid AI Infrastructure Surge
    May 13, 2026, 11:52 AM EDT. Marvell Technology, Inc. shares gained 1.6% in overnight trading after Advanced Micro Devices (AMD) revealed a $10.8 million stake, signaling heightened interest in AI infrastructure providers. Marvell offers diverse products, including networking chips, AI accelerators, and telecom semiconductors, benefiting from growing demand in data center and AI markets. The stock has surged roughly 117% since early March, propelled by winning contracts with hyperscale customers and potential collaborations with Google on AI chips. Despite upbeat fundamentals, retail sentiment on Stocktwits remains 'bearish.' AMD itself is up 128% since late March, led by robust data center revenue growth. Market watchers await upcoming earnings reports from Nvidia on May 20 and Marvell on May 27 for further stock movement clues.

Latest articles

Cerebras IPO Frenzy Tests Wall Street’s $50 Billion AI Chip Bet

Cerebras IPO Frenzy Tests Wall Street’s $50 Billion AI Chip Bet

13 May 2026
Cerebras Systems is set to price its IPO above the $150–$160 per share range, Bloomberg reported, with orders more than 20 times available shares, according to Reuters. The company will offer 30 million shares and begin trading Thursday on Nasdaq under the ticker CBRS. Morningstar estimates the revised range could value Cerebras near $50 billion. Cerebras reported over $500 million in revenue last year but remains unprofitable.
AMD’s Quiet Marvell Stake Puts AI Chip Investors on Alert

AMD’s Quiet Marvell Stake Puts AI Chip Investors on Alert

13 May 2026
Marvell Technology shares rose nearly 10% Wednesday after a filing showed AMD held 65,516 shares at the end of March, valued at $6.49 million then and about $11.8 million at current prices. The disclosure drew attention as Marvell is a key supplier for AI data-center hardware. The Philadelphia SE Semiconductor index is up 64% since March. Analysts raised Marvell’s price targets, citing AI demand and hyperscaler investment.
NIO Stock Is Moving Again As ES8 Sales Put Profit Hopes Back In Play

NIO Stock Is Moving Again As ES8 Sales Put Profit Hopes Back In Play

13 May 2026
NIO’s U.S.-listed shares rose 43.5 cents to $6.515 Wednesday, valuing the company at about $13.6 billion, as April deliveries climbed 22.8% to 29,356 vehicles. The ES8 SUV accounted for 44% of April’s volume. NIO’s first-quarter results are due May 21. The company remains smaller than rivals XPeng, Li Auto, and BYD.

Popular

SELLAS Stock Jumps After AML Trial Moves Two Events From Final Readout

SELLAS Stock Jumps After AML Trial Moves Two Events From Final Readout

13 May 2026
SELLAS Life Sciences said its pivotal REGAL leukemia trial has recorded 78 of 80 events needed for final analysis, triggering a rise in after-hours trading. The company reported a first-quarter net loss of $8.4 million but ended March with $107.1 million in cash. Research and development spending increased to $5.1 million. SELLAS expects its cash to fund operations for at least 12 months.
Nebius (NBIS) Stock Rockets 350% on AI Boom – Bubble or Breakout? Experts Weigh In
Previous Story

‘Vineland ramp’ or bust? Nebius’ Q3 countdown, Microsoft mega‑deal and stock‑split buzz — what investors need to know now

Crypto Alert: Momentum (MMT) Token Rockets 700% as Binance, OKX & Bitget Rush to List the Hot New Sui DeFi Coin
Next Story

Crypto Alert: Momentum (MMT) Token Rockets 700% as Binance, OKX & Bitget Rush to List the Hot New Sui DeFi Coin

Go toTop